Priming affects the activity of a specific region of the promoter of the human beta interferon gene

Mol Cell Biol. 1990 Feb;10(2):854-8. doi: 10.1128/mcb.10.2.854-858.1990.

Abstract

Treatment of Daudi or HeLa cells with human interferon (IFN) alpha 8 before induction with either poly(I)-poly(C) or Sendai virus resulted in an 8- to 100-fold increase in IFN production. The extent of priming in Daudi cells paralleled the increase in the intracellular content of IFN-beta mRNA. IFN-alpha mRNA remained undetectable in poly(I)-poly(C)-treated Daudi cells either before or after priming. An IFN-resistant clone of Daudi cells was found to produce 4- to 20-fold more IFN after priming, indicating that priming was unrelated to the phenotype of IFN sensitivity. IFN treatment of either Daudi or HeLa cells transfected with the human IFN-beta promoter (-282 to -37) linked to the chloramphenicol acetyltransferase (CAT) gene resulted in an increase in CAT activity after induction with poly(I)-poly(C) or Sendai virus. A synthetic double-stranded oligonucleotide corresponding to an authentic 30-base-pair (bp) region of the human IFN-beta promoter between positions -91 and -62 was found to confer virus inducibility upon the reporter CAT gene in HeLa cells. IFN treatment of HeLa cells transfected with this 30-bp region of the IFN-beta promoter in either the correct or reversed orientation also increased CAT activity upon subsequent induction. IFN treatment alone had no detectable effect on the activity of either the 30-bp region or the complete human IFN promoter.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line
  • Cycloheximide / pharmacology
  • Gene Expression
  • Gene Expression Regulation*
  • Genes*
  • HeLa Cells
  • Humans
  • Interferon Type I / genetics*
  • Interferon Type I / pharmacology
  • Parainfluenza Virus 1, Human / genetics
  • Poly I-C / pharmacology
  • Promoter Regions, Genetic* / drug effects
  • RNA, Messenger / genetics
  • Recombinant Proteins
  • Transcription, Genetic / drug effects

Substances

  • Interferon Type I
  • RNA, Messenger
  • Recombinant Proteins
  • Cycloheximide
  • Poly I-C